Lucieli Ceolin - Search Results

Year	Number of Results
2010	1
2011	1
2012	5
2013	2
2014	2
2016	3
2018	1
2019	3
2020	1
2021	1
2022	1
2023	1
2024	1

1

Dual targeting of MAPK and PI3K pathways unlocks redifferentiation of Braf-mutated thyroid cancer organoids.

Lasolle H, Schiavo A, Tourneur A, Gillotay P, de Faria da Fonseca B, Ceolin L, Monestier O, Aganahi B, Chomette L, Kizys MML, Haenebalcke L, Pieters T, Goossens S, Haigh J, Detours V, Maia ALS, Costagliola S, Romitti M. Lasolle H, et al. Among authors: ceolin l. Oncogene. 2024 Jan;43(3):155-170. doi: 10.1038/s41388-023-02889-y. Epub 2023 Nov 20. Oncogene. 2024. PMID: 37985676 Free PMC article.

2

Medullary thyroid carcinoma beyond surgery: advances, challenges, and perspectives.

Ceolin L, Duval MADS, Benini AF, Ferreira CV, Maia AL. Ceolin L, et al. Endocr Relat Cancer. 2019 Aug 1;26(9):R499-R518. doi: 10.1530/ERC-18-0574. Endocr Relat Cancer. 2019. PMID: 31252403 Review.

3

Signaling pathways in follicular cell-derived thyroid carcinomas (review).

Romitti M, Ceolin L, Siqueira DR, Ferreira CV, Wajner SM, Maia AL. Romitti M, et al. Among authors: ceolin l. Int J Oncol. 2013 Jan;42(1):19-28. doi: 10.3892/ijo.2012.1681. Epub 2012 Oct 29. Int J Oncol. 2013. PMID: 23128507 Review.

4

Scapineli JO, Ceolin L, Puñales MK, Dora JM, Maia AL. Scapineli JO, et al. Among authors: ceolin l. Fam Cancer. 2016 Oct;15(4):625-33. doi: 10.1007/s10689-016-9892-6. Fam Cancer. 2016. PMID: 26920351 Review.

5

Molecular basis of medullary thyroid carcinoma: the role of RET polymorphisms.

Ceolin L, Siqueira DR, Romitti M, Ferreira CV, Maia AL. Ceolin L, et al. Int J Mol Sci. 2012;13(1):221-39. doi: 10.3390/ijms13010221. Epub 2011 Dec 27. Int J Mol Sci. 2012. PMID: 22312249 Free PMC article. Review.

6

Global DNA methylation profile in medullary thyroid cancer patients.

Ceolin L, Goularte APP, Ferreira CV, Romitti M, Maia AL. Ceolin L, et al. Exp Mol Pathol. 2018 Aug;105(1):110-114. doi: 10.1016/j.yexmp.2018.06.003. Epub 2018 Jun 21. Exp Mol Pathol. 2018. PMID: 29935954

7

The BRAF^V600E mutation analysis and risk stratification in papillary thyroid carcinoma.

Scheffel RS, de Cristo AP, Romitti M, Vargas CVF, Ceolin L, Zanella AB, Dora JM, Maia AL. Scheffel RS, et al. Among authors: ceolin l. Arch Endocrinol Metab. 2021 May 18;64(6):751-757. doi: 10.20945/2359-3997000000285. Arch Endocrinol Metab. 2021. PMID: 34033285 Free PMC article.

8

The rare intracellular RET mutation p.Ser891Ala in an apparently sporadic medullary thyroid carcinoma: a case report and review of the literature.

Blom CB, Ceolin L, Romitti M, Siqueira D, Maia AL. Blom CB, et al. Among authors: ceolin l. Arq Bras Endocrinol Metabol. 2012 Nov;56(8):586-91. doi: 10.1590/s0004-27302012000800021. Arq Bras Endocrinol Metabol. 2012. PMID: 23295303 Review.

9

Type 2 Deiodinase Thr92Ala Polymorphism Is Not Associated with Cognitive Impairment in Older Adults: A Cross-Sectional Study.

Schwengber WK, Silveira VB, Hetzel GM, Robaina A, Ceolin L, Camelier MT, Goemann I, Dalla Corte RR, Scheffel RS, de Mello RGB, Maia AL, Dora JM. Schwengber WK, et al. Among authors: ceolin l. Metabolites. 2022 Apr 21;12(5):375. doi: 10.3390/metabo12050375. Metabolites. 2022. PMID: 35629879 Free PMC article.

10

Role of RET genetic variants in MEN2-associated pheochromocytoma.

Siqueira DR, Ceolin L, Ferreira CV, Romitti M, Maia SC, Maciel LM, Maia AL. Siqueira DR, et al. Among authors: ceolin l. Eur J Endocrinol. 2014 Jun;170(6):821-8. doi: 10.1530/EJE-14-0084. Epub 2014 Mar 10. Eur J Endocrinol. 2014. PMID: 24616415

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

20 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year